CompletedPhase 3

PPI for Prevention of Post-sphincterotomy Bleeding

China185 participantsStarted 2013-04

Plain-language summary

Endoscopic biliary sphincterotomy is a common and important procedure for biliary access and therapy during endoscopic retrograde cholangiopancreatography (ERCP). Bleeding is one of the important complications related to sphincterotomy. This study determines the role of proton pump inhibitor (PPI) in preventing post-sphincterotomy bleeding in patients undergoing ERCP and sphincterotomy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Consecutive patients undergoing ERCP who will require sphincterotomy Exclusion Criteria: * Previous sphincterotomy/papillotomy * Previous Polya gastrectomy * Patients on maintenance PPI * Pregnant and lactating women * Age \<18 years * Previous liver transplant * unable to consent for study

What they're measuring

Proportion of patients with bleeding after sphincterotomy

Timeframe: 10 days

Trial details

NCT IDNCT01873079

SponsorThe University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-03

View on ClinicalTrials.gov More Bleeding trials